|
Volumn 353, Issue 6299, 2016, Pages 527-528
|
Antiaging trial using young blood stirs concerns
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HEMOGLOBIN;
AGING;
ALZHEIMER DISEASE;
BLOOD BANK;
BLOOD DONOR;
CLINICAL TRIAL (TOPIC);
HEALTH CARE COST;
HEMOGLOBIN BLOOD LEVEL;
HUMAN;
INFLAMMATION;
NONHUMAN;
NOTE;
PATIENT SAFETY;
PLASMA TRANSFUSION;
PRIORITY JOURNAL;
UMBILICAL CORD BLOOD;
ANIMAL;
BLOOD;
BLOOD TRANSFUSION;
ECONOMICS;
MEDICAL FEE;
MOUSE;
NORMAL HUMAN;
PLASMA;
PROCEDURES;
REJUVENATION;
UNITED STATES;
AGING;
ANIMALS;
BLOOD DONORS;
BLOOD TRANSFUSION;
CLINICAL TRIALS AS TOPIC;
FEES, MEDICAL;
HEALTHY VOLUNTEERS;
HUMANS;
MICE;
PLASMA;
REJUVENATION;
UNITED STATES;
|
EID: 84982826627
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.353.6299.527 Document Type: Note |
Times cited : (4)
|
References (0)
|